AKT1 and colorectal cancer: TRIM27 promotes EMT and activates phosphorylated AKT serine/threonine kinases in colorectal cancer cells, promoting cell proliferation, invasion and migration, and inhibiting cell apoptosis (Zhang et al., 2018).